Ticker
TMCICompany Name
TREACE MEDICAL CONCEPTS INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -32.19M | -15.06% | $ 213.75M |
3/31/2025 | $ -36.43M | -17.28% | $ 210.82M |
12/31/2024 | $ -39.72M | -18.97% | $ 209.36M |
9/30/2024 | $ -47.13M | -23.23% | $ 202.86M |
6/30/2024 | $ -48.72M | -24.54% | $ 198.53M |
3/31/2024 | $ -40.79M | -20.81% | $ 196.03M |
12/31/2023 | $ -36.55M | -19.53% | $ 187.12M |
9/30/2023 | $ -35.6M | -20.38% | $ 174.68M |
6/30/2023 | $ -31.19M | -18.68% | $ 166.97M |
3/31/2023 | $ -36.97M | -23.85% | $ 154.99M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for TREACE MEDICAL CONCEPTS INC is calculated as follows: EBITDA [ $ 319K ] / Revenues [ $ 57.37M ]
(=) EBITDA % [ 0.56% ]
Minimum
Sep 30, 2022
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.29K |
---|---|
min | -75.07% |
max | 97.73% |
average | 16.12% |
median | 14.72% |
std | 26.88% |